Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
pediatric
Biotech
J&J posts adolescent myasthenia gravis data on $6B FcRn blocker
J&J has burnished the evidence for nipocalimab, adding a sliver of data in adolescents with gMG to the case for its near-approval FcRn blocker.
Nick Paul Taylor
Oct 15, 2024 9:25am
FDA OKs Tandem’s automated insulin algorithm for toddlers
Nov 8, 2023 10:16am
FDA expands OK for Etiometry's NICU AI
Aug 2, 2023 3:40pm
Applied fails phase 3 trial, plans to seek approval anyway
Apr 24, 2023 9:10am
Wireless pacemakers for kids show promise, but challenges remain
Apr 12, 2023 10:00am
Neurocrine's $45M bet goes 0 for 2 with rare epilepsy flop
Dec 7, 2022 7:20am
